| A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome | Phase 3 | Bristol-Myers Squibb | <1 mi |
| The Myelin Disorders Biorepository Project | — | Children's Hospital of Philadelphia | <1 mi |
| Innovations in Genicular Outcomes Registry | — | Pacira Pharmaceuticals, Inc | <1 mi |
| Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry | — | Duke University | <1 mi |
| MDR - Comprehensive Primary Revision Stems PMCF | — | Zimmer Biomet | <1 mi |
| RA-PRO PRAGMATIC TRIAL | Phase 3 | University of Alabama at Birmingham | <1 mi |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | Phase 2/3 | Olatec Therapeutics LLC | <1 mi |
| Biologic Therapy to Prevent Osteoarthritis After ACL Injury | Early 1 | University of California, Los Angeles | <1 mi |
| SMR Stemless Reverse Vs SMR Reverse Shoulder System | N/A | Limacorporate S.p.a | <1 mi |
| The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis | N/A | University of California, Davis | <1 mi |
| EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) | N/A | DePuy Orthopaedics | <1 mi |
| Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients | N/A | University of California, Davis | <1 mi |
| Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial | N/A | University of California, Davis | <1 mi |
| Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | Phase 1 | National Cancer Institute (NCI) | <1 mi |
| Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis | Phase 1 | Sonoma Biotherapeutics, Inc. | <1 mi |
| A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic | — | Sonoma Biotherapeutics, Inc. | <1 mi |
| Rheumatoid Arthritis Shared Decision Making | N/A | VA Office of Research and Development | <1 mi |
| Platelet Rich Plasma Injections In Young And Old Human Subjects | Phase 2 | University of California, San Francisco | <1 mi |
| Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis | Phase 3 | Duke University | <1 mi |
| Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease | — | University of Colorado, Denver | <1 mi |
| AETOS Shoulder System | — | Smith & Nephew, Inc. | <1 mi |
| A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease | Phase 4 | Janssen Research & Development, LLC | <1 mi |
| A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) | Phase 4 | Eli Lilly and Company | <1 mi |
| A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain | Phase 2 | Eli Lilly and Company | <1 mi |
| Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response | Phase 3 | MoonLake Immunotherapeutics AG | <1 mi |
| A Study of Dotinurad Versus Allopurinol in Participants With Gout | Phase 3 | Crystalys Therapeutics | <1 mi |
| Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug | Phase 3 | MoonLake Immunotherapeutics AG | <1 mi |
| Effect of Anti-inflammatory Diet in Osteoarthritis | N/A | University of California, San Diego | <1 mi |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis | Phase 2 | Janssen Research & Development, LLC | <1 mi |
| R-2487 in Patients With Rheumatoid Arthritis | Phase 1 | Rise Therapeutics LLC | <1 mi |
| Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy | N/A | University of California, San Diego | <1 mi |
| Persona Revision Knee System Outcomes | — | Zimmer Biomet | 1 mi |
| Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis | Early 1 | R3 Medical Research | 1 mi |
| Study of GS-0272 in Participants With Rheumatoid Arthritis | Phase 1 | Gilead Sciences | 6 mi |
| Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA | Phase 1 | Neutrolis | 6 mi |
| Nipocalimab in Moderate to Severe Sjogren's Disease | Phase 3 | Janssen Research & Development, LLC | 7 mi |
| A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | Phase 2 | AbbVie | 7 mi |
| A Study of SPY072 in Rheumatic Disease | Phase 2 | Spyre Therapeutics, Inc. | 7 mi |
| AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. | Phase 2 | Artiva Biotherapeutics, Inc. | 7 mi |
| A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee | Phase 2 | Pacira Pharmaceuticals, Inc | 9 mi |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Phase 3 | Takeda | 9 mi |
| A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis | Phase 2/3 | Nature Cell Co. Ltd. | 9 mi |
| Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare | Phase 2 | Atom Therapeutics Co., Ltd | 9 mi |
| Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain | Phase 1 | R3 Stem Cell | 9 mi |
| A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain. | Phase 3 | Paradigm Biopharmaceuticals Ltd. | 10 mi |
| SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization | N/A | CrannMed | 10 mi |
| Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight | Phase 3 | Eli Lilly and Company | 10 mi |
| A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) | Phase 2 | Merck Sharp & Dohme LLC | 10 mi |
| Study of GS-0151 in Participants With Rheumatoid Arthritis | Phase 1 | Gilead Sciences | 11 mi |
| A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | Phase 3 | Amgen | 11 mi |
| A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | Phase 2 | AstraZeneca | 11 mi |
| Effect of Anti-inflammatory Diet in Rheumatoid Arthritis | N/A | University of California, San Diego | 11 mi |
| Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis | N/A | University of California, San Diego | 11 mi |
| Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project | — | University of California, San Diego | 11 mi |
| Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis | N/A | University of California, San Diego | 11 mi |
| A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults | Phase 1 | UCB Biopharma SRL | 13 mi |
| PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT) | — | Scipher Medicine | 13 mi |
| ConsideRAte Study - Splenic Stimulation for RA | N/A | Galvani Bioelectronics | 13 mi |
| Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis | Phase 2 | AbbVie | 14 mi |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee | Phase 3 | Eli Lilly and Company | 14 mi |
| An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis | Phase 2 | Eli Lilly and Company | 14 mi |
| MOTION Clinical Trial | N/A | Moximed | 14 mi |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease | — | TScan Therapeutics, Inc. | 14 mi |
| Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis | Phase 3 | Sun Pharmaceutical Industries Limited | 14 mi |
| A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis | Phase 3 | UCB Biopharma SRL | 14 mi |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) | Phase 1 | UCB Biopharma SRL | 14 mi |
| The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis | N/A | University of Colorado, Denver | 14 mi |
| Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis | N/A | University of California, Los Angeles | 14 mi |
| Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout | Phase 4 | Massachusetts General Hospital | 14 mi |
| Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee | — | Palo Alto Veterans Institute for Research | 16 mi |
| The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients | Phase 2 | Stanford University | 17 mi |
| Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis | N/A | Stanford University | 17 mi |
| A Study of AZD0120 in Autoimmune Diseases | Phase 1 | AstraZeneca | 17 mi |
| Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants | Phase 1 | AstraZeneca | 17 mi |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines | Phase 3 | Takeda | 20 mi |
| At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study] | N/A | SecondWave Systems Inc. | 20 mi |
| Exactech Shoulder Post Market Clinical Follow-up Study | — | Exactech | 22 mi |
| Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis | N/A | Syntr Health Technologies, Inc. | 22 mi |
| Zimmer Biomet Shoulder Arthroplasty PMCF | N/A | Zimmer Biomet | 22 mi |
| The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis | Phase 2 | David Grant U.S. Air Force Medical Center | 32 mi |
| A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) | Phase 2 | Hoffmann-La Roche | 34 mi |
| Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis | N/A | Healeon Medical Inc | 34 mi |
| MISHA Post-Market Clinical Study | N/A | Moximed | 36 mi |
| A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis | Phase 3 | Bristol-Myers Squibb | 45 mi |